Cospanon tablets are mainly used to relieve biliary and intestinal spasms. Its use requires strict avoidance of taboo populations, foods, and specific restrictions to ensure medication safety and effectiveness. The following will explain from three aspects: classification of taboo groups, list of taboo foods, and medication restrictions.

1. Taboo population

(1) Individuals allergic to trihydroxyphenylacetone or its excipients are prohibited from using it, as it may cause allergic reactions such as rash and difficulty breathing.

(2) It is contraindicated for patients with severe liver dysfunction, as impaired drug metabolism may lead to toxic accumulation.

(3) It is contraindicated for glaucoma patients as anticholinergic effects may exacerbate symptoms of elevated intraocular pressure.

(4) Prostatic hyperplasia with urinary retention is prohibited, and drugs may aggravate dysuria.

(5) Pregnant and lactating women are prohibited from using it, as there is a lack of safety data and it may affect the fetus or infant.

2. Forbidden foods

(1) Alcoholic beverages: may enhance the central inhibitory effect of drugs, leading to drowsiness or dizziness.

(2) High fat diet: delays gastric emptying rate, affects drug absorption rate and efficacy stability.

(3) Caffeine drinks: When combined with the stimulating effects of medication, they may cause palpitations or blood pressure fluctuations.

3. Restrictive conditions

(1) Driving restrictions: During medication, drowsiness or blurred vision may occur, and it is necessary to avoid operating machinery or driving vehicles.

(2) Course control: If continuous use is ineffective for more than one week, the medication should be stopped and the diagnosis should be re evaluated.

(3) Combination therapy: It is prohibited to use it in combination with anticholinergic drugs and sedatives, as it may increase the risk of adverse reactions.

(4) Special monitoring: Elderly patients and those with mild to moderate liver damage need to undergo regular assessments of liver function and neurological symptoms.